Novo Nordisk announced results of its STEPwise™ trial, which identified a method of intensifying insulin treatment with …
Articles by ASweetLife Team
Type 2 Diabetics May be Able to Tolerate Higher Doses of Metformin Using Glumetza
A press release issued today by Depomed, Inc. and Santarus, Inc says that according to the clinical trial results, patie…
Byetta Improves Beta-Cell Function in Type 2 Diabetics
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced results from a study comparing the effect of long-term …
Byetta Helps Type 2 Diabetics Achieve Blood Glucose Control
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced results from the first double-blind, placebo-controlled…
Symlin Does Not Increase Risk of Cardiovascular Event, New Study Shows
Amylin Pharmaceuticals, Inc. announced results from an analysis of an integrated database of clinical studies that showe…
Victoza Superior to Januvia, New Study Shows
Late-breaking Novo Nordisk extension data presented at the 70th Annual Scientific Sessions of the American Diabetes Asso…
Novo Nordisk Presents Positive Phase 2 Data for Ultra-Long-Acting Insulin Degludec
According to a Novo Nordisk press release the company presented phase 2 proof-of-concept data for its investigational in…
Abbott Receives FDA Clearance for New FreeStyle Test Strips
Following the recent clearance of its FreeStyle Lite® blood glucose test strips, Abbott announced that it has also recei…
Abbott Receives FDA Clearance for New FreeStyle Test Strips
Following the recent clearance of its FreeStyle Lite® blood glucose test strips, Abbott announced that it has also recei…
Bristol-Myers Squibbs’ Dapagliflozin Demonstrated Improved Glycemic Control in Adults with Type 2 Diabetes
Bristol-Myers announced that findings from a 24-week Phase 3 clinical study, published online in the latest issue of Dia…
